Liberty Wealth Management’s Biogen BIIB Stock Holding History

Liberty Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-511	Closed	-$145K	–	272
2021 Q3	$145K	Hold	511	–	–	0.05%	219
2021 Q2	$177K	Hold	511	–	–	0.07%	148
2021 Q1	$142K	Hold	511	–	–	0.07%	139
2020 Q4	$142K	Hold	511	–	–	0.07%	138
2020 Q3	$145K	Hold	511	–	–	0.09%	121
2020 Q2	$137K	Sell	511 -98	-16%	-$29.5K	0.1%	118
2020 Q1	$193K	Buy	609 +15	+3%	+$4.55K	0.17%	93
2019 Q4	$176K	Buy	594 +448	+307%	+$124K	0.14%	112
2019 Q3	$34K	Sell	146 -451	-76%	-$105K	0.03%	302
2019 Q2	$140K	Buy	597 +358	+150%	+$82.7K	0.12%	135
2019 Q1	$56K	Buy	239 +40	+20%	+$12.6K	0.04%	187
2018 Q4	$59K	Buy	+199	New	+$63.5K	0.04%	173

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Liberty Wealth Management's BIIB Position: Q4 2021 in Review

Liberty Wealth Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 511 shares — an estimated $145K sold.

Liberty Wealth Management first reported a position in BIIB in Q4 2018 and held it in 12 quarters. The position peaked at $193K in Q1 2020. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Liberty Wealth Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Liberty Wealth Management sold 511 Biogen shares in Q4 2021, an estimated $145K.
Liberty Wealth Management first reported a position in Biogen in Q4 2018 and held it in 12 quarters.
Liberty Wealth Management's Biogen position peaked at $193K in Q1 2020.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Liberty Wealth Management's 13F filing for Q4 2021, filed 15 Feb 2022.